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Abstract 
A cross-sectional study was performed on 48 psoriasis Vietnamese patients treated with metformin as an add-on 
for methotrexate and 48 psoriasis patients treated methotrexate alone. The mean PASI scores were 5.25 ± 5.72. 
Total QOL scores had a slight difference between patients treated metformin combined with methotrexate and 
methotrexate alone (62.32 ± 18.1 vs 60.91 ± 19.63). Combined therapy with metformin and methotrexate 
contributes to significantly improve the quality of life for patients with psoriasis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dear Editor, 
 
Psoriasis is a chronic skin disease affecting 
social relations, psychological status, and daily 
activities. Quality of life (QOL) is increasingly 
recognised as an important outcome measure in 
psoriasis patients [1], [2]. Dermatologic treatment of 
psoriasis has become increasingly effective, 
sometimes even using complementary and alternative 
medicine (CAM), contributing to improve the QOL of 
patients [3] significantly. According to some studies 
showed that metformin is a logical add-on therapy for 
patients with psoriasis and metabolic syndrome 
treated with methotrexate. Evaluation of the quality of 
life of patients with psoriasis treated with metformin 
and methotrexate is important. A Metformin therapy 
combined with methotrexate has any impact on the 
QOL of patients with psoriasis? 
A cross-sectional study was performed on 48 
psoriasis patients treated with metformin as an add-on 
for methotrexate, and 48 psoriasis patients treated 
methotrexate alone. The severity of disease was 
calculated by the Psoriasis Area and Severity Index 
(PASI). These patients were interviewed with the 
short-form-36 (SF36) questionnaire to assess their 
quality of life. 
The mean PASI scores were 5.25 ± 5.72. 
Total QOL scores had a slight difference between 
patients treated metformin combined with 
methotrexate and methotrexate alone (62.32 ± 18.1 vs 
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60.91 ± 19.63). Especially in two domains: Role-
physical (59.4 ± 21.3 vs. 58.8 ± 25.2) and social 
functioning (62.5 ± 24.6 vs. 60.15 ± 25.5) (P < 0.01).  
Metformin act through activation of adenosine 
monophosphate-activated protein kinase (AMPK) in 
extracellular signal-related kinase (ERK1/2) signalling 
pathway leading to cell cycle arrest and therefore 
inhibition of cell proliferation, the hallmark of psoriasis. 
AMPK activation not only inhibits iNOS, dendritic, T 
cell and monocyte/macrophage activation but also 
activates IL-10 and TGF-β, thereby exerting its anti-
inflammatory action. The anti-proliferative and anti-
inflammatory action of metformin might have resulted 
in improving the QOL of psoriasis patients [4], [5], [6], 
[7], [8]. 
In conclusion, there is a difference in the 
quality of life in psoriasis patients treated metformin as 
an add-on for methotrexate compared with patients 
treated methotrexate alone. Combined therapy with 
metformin and methotrexate contributes to 
significantly improve the quality of life for patients with 
psoriasis. 
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